Tracy Kuo
Tracy Kuo
Unknown affiliation
Verified email at
Cited by
Cited by
Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program
AL Shaffer, KI Lin, TC Kuo, X Yu, EM Hurt, A Rosenwald, JM Giltnane, ...
Immunity 17 (1), 51-62, 2002
Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells
KI Lin, C Angelin-Duclos, TC Kuo, K Calame
Molecular and cellular biology, 2002
Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR
SM Ranuncolo, JM Polo, J Dierov, M Singer, T Kuo, J Greally, R Green, ...
Nature immunology 8 (7), 705-714, 2007
Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation
J Glanville, TC Kuo, HC von Büdingen, L Guey, J Berka, PD Sundar, ...
Proceedings of the National Academy of Sciences 108 (50), 20066-20071, 2011
Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis
A Palanichamy, L Apeltsin, TC Kuo, M Sirota, S Wang, SJ Pitts, ...
Science translational medicine 6 (248), 248ra106-248ra106, 2014
B cell exchange across the blood-brain barrier in multiple sclerosis
HC von Büdingen, TC Kuo, M Sirota, CJ Van Belle, L Apeltsin, J Glanville, ...
The Journal of clinical investigation 122 (12), 4533-4543, 2012
B lymphocyte-induced maturation protein (Blimp)-1, IFN regulatory factor (IRF)-1, and IRF-2 can bind to the same regulatory sites
TC Kuo, KL Calame
The Journal of Immunology 173 (9), 5556-5563, 2004
ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile
SE Kauder, TC Kuo, O Harrabi, A Chen, E Sangalang, L Doyle, SS Rocha, ...
PloS one 13 (8), e0201832, 2018
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication
J Theruvath, M Menard, BAH Smith, MH Linde, GL Coles, GN Dalton, ...
Nature medicine 28 (2), 333-344, 2022
Mechanisms controlling expression of the RAG locus during lymphocyte development
TC Kuo, MS Schlissel
Current opinion in immunology 21 (2), 173-178, 2009
Repression of BCL-6 is required for the formation of human memory B cells in vitro
TC Kuo, AL Shaffer, J Haddad Jr, YS Choi, LM Staudt, K Calame
The Journal of experimental medicine 204 (4), 819-830, 2007
Preclinical evaluation of allogeneic CAR T cells targeting BCMA for the treatment of multiple myeloma
C Sommer, B Boldajipour, TC Kuo, T Bentley, J Sutton, A Chen, T Geng, ...
Molecular therapy 27 (6), 1126-1138, 2019
The restricted DH gene reading frame usage in the expressed human antibody repertoire is selected based upon its amino acid content
J Benichou, J Glanville, ETL Prak, R Azran, TC Kuo, J Pons, C Desmarais, ...
The Journal of Immunology 190 (11), 5567-5577, 2013
Blimp-1/Prdm1 alternative promoter usage during mouse development and plasma cell differentiation
MAJ Morgan, E Magnusdottir, TC Kuo, C Tunyaplin, J Harper, SJ Arnold, ...
Molecular and cellular biology 29 (21), 5813-5827, 2009
Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 …
NJ Lakhani, LQM Chow, JF Gainor, P LoRusso, KW Lee, HC Chung, ...
The Lancet Oncology 22 (12), 1740-1751, 2021
Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity
TC Kuo, A Chen, O Harrabi, JT Sockolosky, A Zhang, E Sangalang, ...
Journal of Hematology & Oncology 13, 1-19, 2020
Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPα
J Sim, JT Sockolosky, E Sangalang, S Izquierdo, D Pedersen, ...
MAbs 11 (6), 1036-1052, 2019
Therapeutic antibodies and their uses
TCC Kuo, JFC Riggers, W Chen, AS Chen, ED Pascua, TJ Van Blarcom, ...
US Patent 9,969,809, 2018
Constructs having a SIRP-α domain or variant thereof
J Pons, L Deming, C Goodman, BJ Sim, SE Kauder, H Wan, TCC Kuo
US Patent 10,259,859, 2019
Chimeric antigen receptors targeting B-cell maturation antigen
TCC Kuo, BA Boldajipour, JFC Riggers, P Duchateau, R Galetto, ...
US Patent 10,294,304, 2019
The system can't perform the operation now. Try again later.
Articles 1–20